The United Kingdom’s National Institute for Health and Care Excellence guidance on implantable cardiac defibrillator (ICD) therapy recommend ICD in those with left ventricular dysfunction and a high risk of sudden cardiac death (SCD). SCD accounts for 30% deaths in non-ischaemic dilated cardiomyopathy (DCM), however risk stratifying and predicting SCD in DCM is a major management challenge. We present two cases demonstrating the potential role of cardiac magnetic resonance imaging in risk stratifying DCM.
|Number of pages||2|
|Journal||Open Cardiovascular Medicine Journal|
|Publication status||Published - 2015|
- Dilated Cardiomyopathy
- Magnetic Resonance Imaging
- Sudden Cardiac Death
- Ventricular Tachycardia